Back

Interleukin-6 and cardiovascular prognosis in apparently healthy individuals

29 August 2025 (08:15 - 08:33)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Berkan Kurt

University Hospital Aachen, Aachen (Germany)

4 More presentations in this session

Presentation thumbnail
Coronary and systemic inflammation: the ORFAN study
Doctor K. Chan (Oxford, GB)
Slides Video
Presentation thumbnail
hsCRP and Long-term CV Outcomes among SMuRF-Less Women
Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
C-reactive protein and cardiovascular risk in the general population
Professor F. Kahles (Aachen, DE)
Slides Video
Presentation thumbnail
LoDoCo2: Effect of Colchicine on Clonal Hematopoiesis and Inflammatory Biomarkers
Mr N. Mohammadnia (Nijmegen, NL)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Independent and cumulative prognostic information of C-reactive protein and interleukin-6 to predict major adverse cardiovascular events and death in post acute coronary syndrome patients
thumbnail
Congress Presentation
Interleukin-6 inclusion adds value to the SMART risk score for prediction of cardiovascular death in patients with established ASCVD
thumbnail
Congress Session
Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources